CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 215 enrolled
Drug / intervention
Lansoprazole +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02175901
NCT02175901Phase 4Completed

Prospective, Randomized Controlled Trial Comparing Amoxicillin and Metronidazole Based Bismuth-containing Quadruple Therapy With Amoxicillin and Clarithromycin Based Quadruple Therapy for First-line Helicobacter Pylori Eradication

Shanghai Jiao Tong University School of Medicine·interventional·Posted Jun 26, 2014·Updated Feb 3, 2015

In Brief

A Phase 4 clinical trial evaluating Lansoprazole, Bismuth Potassium Citrate, and 3 other interventions for Dyspepsia and Peptic Ulcer. Completed, enrolled 215 participants across 1 site.

Detailed Summary

No trial has examined the the efficacy of amoxicillin and metronidazole based quadruple therapy for Helicobacter pylori treatment. The study aims to compare the effectiveness and safety of 14-day amoxicillin-/metronidazole-based quadruple regiment and classical quadruple regiment for Helicobacter pylori eradication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 26, 2014
Enrollment StartJul 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 12.0 years ago

Interventions

Lansoprazoledrug

antisecretory drug of each quadruple therapy

Bismuth Potassium Citratedrug

one component of each quadruple therapy

Amoxicillindrug

antibiotic of each quadruple therapy

Metronidazoledrug

antibiotic of the amoxicillin/metronidazole-based quadruple therapy

Clarithromycindrug

antibiotic of the amoxicillin/clarithromycin-based quadruple therapy